stiripentol has been researched along with Aura in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.57) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 8 (22.86) | 29.6817 |
| 2010's | 12 (34.29) | 24.3611 |
| 2020's | 5 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, P; Chatterjee, BK; Chatterjee, T; Das, G; Dhar, J; Ghosh, S | 1 |
| Perry, MS | 1 |
| Arenas Cabrera, CM; Ben-Menachem, E; Critchley, D; Crockett, J; Gunning, B; Morrison, G; Tayo, B; Toledo, M; VanLandingham, K; Wray, L | 1 |
| Bjørnvold, M; Burns, ML; Heger, K; Johannessen Landmark, C; Johannessen, SI; Lund, C; Sætre, E | 1 |
| Canafoglia, L; Castellotti, B; D'Arrigo, S; DiFrancesco, JC; Freri, E; Gellera, C; Granata, T; Magri, S; Messina, G; Ragona, F; Solazzi, R; Vannicola, C | 1 |
| Nickels, KC; Wirrell, EC | 1 |
| Hashimoto, T; Kitaoka, T; Kyotani, S; Morimoto, M; Shimakawa, S | 1 |
| Ito, S; Oguni, H | 1 |
| Ohtsuka, Y | 1 |
| Specchio, N; Trivisano, M; Vigevano, F | 1 |
| Rho, JM | 1 |
| Paolino, MC; Parisi, P; Prezioso, G; Stagi, S; Verrotti, A | 1 |
| Chiron, C | 2 |
| Andrade, DM; Arzimanoglou, A; Camfield, CS; Camfield, PR; Chiron, C; Cramer, JA; French, JA; Kossoff, E; Mula, M; Nabbout, R | 1 |
| Perucca, E; Prunetti, P | 1 |
| Chiron, C; Nabbout, R | 1 |
| Boor, R; Brandt, C; Holert, N; Jürgens, U; Korn-Merker, E; May, TW; Mayer, T; Rambeck, B | 1 |
| Bergin, AM; Connolly, M | 1 |
| Ben-Ari, Y; Chiron, C; Gozlan, H; Quilichini, PP | 1 |
| Appleton, RE; Macleod, S | 1 |
| Brouwer, OF; Goorhuis, JF; Verkade, HJ | 1 |
| Blehaut, HM; Guyot, M; Levy, RH; Loiseau, P; Moreland, TA; Tor, J | 1 |
| Bebin, M; Bleck, TP | 1 |
| Patsalos, PN; Sander, JW | 1 |
| Chiron, C; d'Athis, P; Dulac, O; Olive, G; Pous, G; Renard, F; Rey, E; Tran, A; Vauzelle-Kervroedan, F | 1 |
| Grippo, J | 1 |
| Bishop, FE; d'Athis, P; Gillardin, JM; Kunze, KL; Labroo, R; Lepage, F; Levy, RH; Mather, GG; Olive, G; Pons, G; Rey, E; Rousseau, M; Thummel, KE; Trager, WF; Tran, A; Vincent, JC; Wurden, CJ | 1 |
| Blehaut, H; Chiron, C; d'Athis, P; Dulac, O; Musial, C; Perez, J; Rey, E; Vincent, J | 1 |
| Trevathan, E | 1 |
| Dulac, O | 1 |
| Aurousseau, M; Ilies, A; Wegmann, R | 2 |
| Vincent, JC | 1 |
18 review(s) available for stiripentol and Aura
| Article | Year |
|---|---|
New and Emerging Medications for Treatment of Pediatric Epilepsy.
Topics: Anticonvulsants; Cannabidiol; Child; Dioxolanes; Epilepsy; Fenfluramine; Humans; Piperidines; Pregnanolone; Pyridines | 2020 |
Stiripentol in the Management of Epilepsy.
Topics: Animals; Anticonvulsants; Dioxolanes; Epilepsy; Humans | 2017 |
[Treatment of pediatric epilepsy].
Topics: Adolescent; Amines; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Dioxolanes; Drug Approval; Drug Substitution; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Infant; Lamotrigine; Levetiracetam; Patient Education as Topic; Piracetam; Practice Guidelines as Topic; Topiramate; Triazines; Triazoles; Valproic Acid | 2014 |
[New antiepileptic drugs: characteristics and clinical applications].
Topics: Amines; Anticonvulsants; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Dioxolanes; Drug Approval; Drug Interactions; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Japan; Lamotrigine; Levetiracetam; Piracetam; Safety; Topiramate; Triazines; Triazoles | 2014 |
Pharmacological considerations in the use of stiripentol for the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Dioxolanes; Drug Resistant Epilepsy; Epilepsy; Humans; Off-Label Use | 2016 |
Stiripentol and vigabatrin current roles in the treatment of epilepsy.
Topics: Anticonvulsants; Combined Modality Therapy; Dioxolanes; Epilepsy; Humans; Infant; Treatment Outcome; Vigabatrin | 2016 |
Treatment issues for children with epilepsy transitioning to adult care.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Cannabidiol; Child; Congresses as Topic; Diet, Ketogenic; Dioxolanes; Epilepsy; Humans; Transition to Adult Care; Treatment Outcome; Vigabatrin; Young Adult | 2017 |
New and forthcoming anti-epileptic drugs.
Topics: Acetamides; Anticonvulsants; Clinical Trials as Topic; Dioxolanes; Drug Approval; Drug Discovery; Epilepsy; Humans; Lacosamide; Remission Induction; Triazoles | 2011 |
Stiripentol: an example of antiepileptic drug development in childhood epilepsies.
Topics: Anticonvulsants; Benzodiazepines; Child; Clobazam; Cytochrome P-450 Enzyme System; Dioxolanes; Epilepsy; Humans; Randomized Controlled Trials as Topic | 2012 |
New antiepileptic drug therapies.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenylcarbamates; Phenytoin; Piracetam; Propylene Glycols; Thiazines; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 2002 |
Stiripentol.
Topics: Animals; Anticonvulsants; Brain; Child; Clinical Trials as Topic; Dioxolanes; Epilepsy; Humans | 2007 |
The new antiepileptic drugs.
Topics: Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsies, Partial; Epilepsy; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Pregabalin; Topiramate; Triazines; Vigabatrin; Zonisamide | 2007 |
New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.
Topics: Adolescent; Adult; Animals; Anticonvulsants; Child; Child, Preschool; Cross-Over Studies; Dioxolanes; Double-Blind Method; Epilepsy; Flunarizine; Humans; Midazolam; Middle Aged; Phenytoin; Pilot Projects; Prodrugs | 1994 |
Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Topics: Acetamides; Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenobarbital; Phenylcarbamates; Piracetam; Propylene Glycols; Risk Factors; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 1994 |
[Treatment of the epilepsy: new drugs].
Topics: Acetates; Amines; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Clobazam; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Oxcarbazepine; Phenylcarbamates; Propylene Glycols; Topiramate; Triazines; Vigabatrin; Zonisamide | 1996 |
Epileptic encephalopathy.
Topics: Adolescent; Age Factors; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Brain Diseases; Child; Child, Preschool; Clobazam; Dioxolanes; Electroencephalography; Epilepsies, Myoclonic; Epilepsy; Humans; Infant; Infant, Newborn; Landau-Kleffner Syndrome; Spasms, Infantile; Treatment Outcome | 2001 |
Stiripentol. BCX 2600.
Topics: Clinical Trials as Topic; Dioxolanes; Drug Interactions; Epilepsy; Humans | 2002 |
Stiripentol.
Topics: Animals; Anticonvulsants; Brain; Dioxolanes; Drug Interactions; Drugs, Investigational; Electroencephalography; Epilepsy; Evoked Potentials; Humans | 1991 |
5 trial(s) available for stiripentol and Aura
| Article | Year |
|---|---|
A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Area Under Curve; Cannabidiol; Dioxolanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Valproic Acid; Young Adult | 2020 |
New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.
Topics: Adolescent; Adult; Animals; Anticonvulsants; Child; Child, Preschool; Cross-Over Studies; Dioxolanes; Double-Blind Method; Epilepsy; Flunarizine; Humans; Midazolam; Middle Aged; Phenytoin; Pilot Projects; Prodrugs | 1994 |
Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dioxolanes; Drug Interactions; Epilepsy; Female; Humans; Infant; Male | 1996 |
Stiripentol: efficacy and tolerability in children with epilepsy.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Child; Child, Preschool; Dioxolanes; Drug Therapy, Combination; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Placebos; Single-Blind Method; Treatment Outcome | 1999 |
Epilepsy syndrome-specific anti-epileptic drug therapy for children.
Topics: Adult; Anticonvulsants; Child; Dioxolanes; Epilepsies, Myoclonic; Epilepsy; Humans; Infant; Syndrome | 2000 |
13 other study(ies) available for stiripentol and Aura
| Article | Year |
|---|---|
The role of isoaspartate in fibrillation and its prevention by Protein-L-isoaspartyl methyltransferase.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Anticonvulsants; Aspartic Acid; Benzothiazoles; Brain; Dioxolanes; Epilepsy; Humans; Isoaspartic Acid; Neurons; PC12 Cells; Peptides; Protein D-Aspartate-L-Isoaspartate Methyltransferase; Rats; Structure-Activity Relationship; Valproic Acid | 2020 |
Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Child; Child, Preschool; Clobazam; Dioxolanes; Drug Monitoring; Epilepsies, Myoclonic; Epilepsy; Female; Humans; Levetiracetam; Male; Middle Aged; Norway; Retrospective Studies; Valproic Acid; Young Adult | 2020 |
Severe epilepsy in CNTNAP2-related Pitt-Hopkins-like syndrome successfully treated with stiripentol.
Topics: Dioxolanes; Epilepsy; Humans; Hyperventilation; Intellectual Disability; Membrane Proteins; Nerve Tissue Proteins | 2021 |
Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
Topics: Anticonvulsants; Child, Preschool; Dioxolanes; Drug Therapy, Combination; Epilepsies, Myoclonic; Epilepsy; Female; Fructose; Humans; Topiramate; Valproic Acid | 2018 |
Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
Topics: Age of Onset; Anticonvulsants; Autistic Disorder; Benzodiazepines; Cadherins; Child; Clobazam; Cognition Disorders; Dioxolanes; Drug Resistant Epilepsy; Drug Therapy, Combination; Epilepsies, Myoclonic; Epilepsy; Female; Fever; Humans; Intellectual Disability; Protocadherins; Syndrome; Treatment Outcome; Valproic Acid | 2015 |
Inhibition of Lactate Dehydrogenase to Treat Epilepsy.
Topics: Animals; Anticonvulsants; Dioxolanes; Enzyme Inhibitors; Epilepsy; Humans; L-Lactate Dehydrogenase; Safrole | 2015 |
Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication.
Topics: Adult; Age Factors; Anticonvulsants; Body Weight; Child; Child, Preschool; Dioxolanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Epilepsy; Humans; Phenobarbital; Phenytoin; Regression Analysis; Retrospective Studies; Sex Factors; Young Adult | 2012 |
Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels.
Topics: Animals; Animals, Newborn; Anticonvulsants; Chloride Channels; Dioxolanes; Disease Models, Animal; Drug Interactions; Epilepsy; Excitatory Postsynaptic Potentials; GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Neural Inhibition; Nipecotic Acids; Oximes; Patch-Clamp Techniques; Pentobarbital; Pyramidal Cells; Rats; Rats, Wistar; Receptors, GABA-A; Synaptic Transmission | 2006 |
Acute hepatic injury in a child with Dravet syndrome: no protective effect of stiripentol.
Topics: Anticonvulsants; Child; Dioxolanes; Epilepsy; Female; Humans; Liver Failure; Treatment Failure | 2008 |
Stiripentol kinetics in epilepsy: nonlinearity and interactions.
Topics: Administration, Oral; Adult; Anticonvulsants; Chromatography, High Pressure Liquid; Dioxolanes; Dioxoles; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Female; Humans; Kinetics; Male; Middle Aged | 1984 |
Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constants.
Topics: Adult; Anticonvulsants; Caffeine; Carbon Dioxide; Carbon Isotopes; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dextromethorphan; Dioxolanes; Epilepsy; Humans; Hydrocortisone; In Vitro Techniques; Mixed Function Oxygenases; Reference Values; Time Factors | 1997 |
[Pharmaco-cellular enzymology of the mechanism of action of stiripentol in cardiazol-induced epilepsy. II. Glucose metabolism].
Topics: Animals; Anticonvulsants; Brain; Brain Chemistry; Dioxolanes; Energy Metabolism; Epilepsy; Female; Glucose; Glucosephosphate Dehydrogenase; Glycogen; Male; Pentylenetetrazole; Rats; Rats, Inbred Strains | 1978 |
[Pharmaco-cellular enzymology of the mechanism of action of stiripentol in cardiazol-induced epilepsy. III. Protein, nucleoprotein, lipid, and proteoglycan metabolism].
Topics: 3-Hydroxyacyl CoA Dehydrogenases; 4-Aminobutyrate Transaminase; Animals; Anticonvulsants; Arylsulfatases; Brain; Brain Chemistry; Dioxolanes; Epilepsy; Female; Lipid Metabolism; Male; Nerve Tissue Proteins; Nucleoproteins; Pentylenetetrazole; Proteoglycans; Rats; Rats, Inbred Strains; Solubility | 1978 |